NovaCina, a global contract development and manufacturing organization (CDMO), has today announced the expansion of its facility in Perth, Australia with...
The Nobel Prize in Physiology or Medicine has been awarded to American researchers Victor Ambros and Gary Ruvkun for their pioneering discovery of microR...
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and ten23 health, the human-centri...
Enzene, a fully integrated CDMO with services spanning discovery, development and commercial supply, today announced it is to launch its new EnzeneX&trad...
Indiana facility will combine research, manufacturing and the latest technology to innovate new production methods and scale glo...
Hovione Farmaciência, S.A.(“HOVIONE”) and Zerion Pharma A/S (“ZERION”) today announced that they have expanded their part...
Renaissance Lakewood, LLC (“Renaissance”), a leading global contract development and manufacturing organization (“CDMO”) is proud...
Learnings will be used in the clinical development programs of NET-targeting therapies such as Citryll’s lead anti-inflammatory candidate CIT-013 ...
This ADHD Awareness Month, we stand with the ADHD community. Alora Pharmaceuticals, LLC, the largest U.S. manufacturer of methylphenidate medications,...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced the completion of the acquisition of CN201 from Curon Biopharmaceutical ...
LeaderMed Group (LeaderMed), a global pharmaceutical development company, and Combiphar, a leading Indonesian pharmaceutical company in Southeast Asia, ann...
Thermo Fisher Scientific Inc., the world leader in serving science, announced the launch of the international CorEvitas Adolescent Atopic Dermatitis (AD)...
Olympus Corporation (Olympus), a global MedTech company committed to making people’s lives healthier, safer and more fulfilling, today announced th...
As President of EMEA at Vision Johnson & Johnson, Jacqueline Henderson is at the forefront of innovation in ophthalmology, overseeing the development...
© 2025 Biopharma Boardroom. All Rights Reserved.
